Unknown

Dataset Information

0

Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors.


ABSTRACT: To develop unique small-molecule inhibitors of hepatitis C virus (HCV), thiophen urea (TU) derivatives were synthesised and screened for HCV entry inhibitory activities. Among them, seven TU compounds exhibited portent anti-viral activities against genotypes 1/2 (EC50 < 30 nM) and subsequently, they were further investigated; based on the pharmacological, metabolic, pharmacokinetic, and safety profiles, J2H-1701 was selected as the optimised lead compound as an HCV entry inhibitor. J2H-1701 possesses effective multi-genotypic antiviral activity. The docking results suggested the potential interaction of J2H-1701 with the HCV E2 glycoprotein. These results suggest that J2H-1701 can be a potential candidate drug for the development of HCV entry inhibitors.

SUBMITTER: Ryu HC 

PROVIDER: S-EPMC7822064 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4789664 | biostudies-literature
| S-EPMC8097465 | biostudies-literature
| S-EPMC6476926 | biostudies-literature
| S-EPMC5923087 | biostudies-other
| S-EPMC4203399 | biostudies-literature
| S-EPMC6015499 | biostudies-literature
| S-EPMC9611651 | biostudies-literature
| S-EPMC6272711 | biostudies-literature
| S-EPMC3954896 | biostudies-literature
| S-EPMC4050313 | biostudies-literature